Blair William & CO Illumina, Inc. Transaction History

Blair William & CO

$33.4 Billion
Q3 2024

A detailed history of Blair William & CO transactions in Illumina, Inc. stock. As of the latest transaction made, Blair William & CO holds 24,177 shares of ILMN stock, worth $3.26 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

24,177

Previous 24,981 3.22%

Holding current value

$3.26 Million

Previous $2.61 Million 20.91%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$105.28 - $135.9 $84,645 - $109,263	-804 Reduced 3.22%	24,177 $3.15 Million
Q2 2024 Aug 12, 2024	SELL	$101.05 - $133.57 $116,106 - $153,471	-1,149 Reduced 4.4%	24,981 $2.61 Million
Q1 2024 May 09, 2024	SELL	$127.73 - $147.2 $50,708 - $58,438	-397 Reduced 1.5%	26,130 $3.59 Million
Q4 2023 Feb 12, 2024	SELL	$92.79 - $142.53 $212,860 - $326,963	-2,294 Reduced 7.96%	26,527 $3.69 Million
Q3 2023 Nov 09, 2023	SELL	$128.91 - $192.44 $463,689 - $692,206	-3,597 Reduced 11.1%	28,821 $3.96 Million
Q2 2023 Aug 11, 2023	SELL	$183.43 - $232.67 $552,674 - $701,034	-3,013 Reduced 8.5%	32,418 $6.08 Million
Q1 2023 May 12, 2023	SELL	$193.75 - $232.55 $561,875 - $674,395	-2,900 Reduced 7.57%	35,431 $8.24 Million
Q4 2022 Feb 10, 2023	BUY	$187.24 - $242.74 $222,253 - $288,132	1,187 Added 3.2%	38,331 $7.75 Million
Q3 2022 Nov 09, 2022	SELL	$177.23 - $227.44 $414,186 - $531,527	-2,337 Reduced 5.92%	37,144 $7.09 Million
Q2 2022 Aug 10, 2022	SELL	$181.58 - $368.0 $422,355 - $855,968	-2,326 Reduced 5.56%	39,481 $7.28 Million
Q1 2022 May 13, 2022	SELL	$303.87 - $423.8 $1.12 Million - $1.56 Million	-3,679 Reduced 8.09%	41,807 $14.6 Million
Q4 2021 Feb 14, 2022	BUY	$347.28 - $421.83 $196,213 - $238,333	565 Added 1.26%	45,486 $17.3 Million
Q3 2021 Nov 12, 2021	BUY	$405.61 - $524.84 $88,017 - $113,890	217 Added 0.49%	44,921 $18.2 Million
Q2 2021 Aug 12, 2021	SELL	$372.84 - $481.5 $170,760 - $220,527	-458 Reduced 1.01%	44,704 $21.2 Million
Q1 2021 May 13, 2021	BUY	$361.28 - $504.76 $1.03 Million - $1.44 Million	2,854 Added 6.75%	45,162 $17.3 Million
Q4 2020 Feb 09, 2021	SELL	$292.7 - $370.96 $120,299 - $152,464	-411 Reduced 0.96%	42,308 $15.7 Million
Q3 2020 Nov 06, 2020	SELL	$268.51 - $400.74 $1.45 Million - $2.17 Million	-5,411 Reduced 11.24%	42,719 $13.2 Million
Q2 2020 Aug 12, 2020	BUY	$256.46 - $373.01 $403,924 - $587,490	1,575 Added 3.38%	48,130 $17.8 Million
Q1 2020 May 11, 2020	SELL	$209.2 - $335.53 $358,359 - $574,762	-1,713 Reduced 3.55%	46,555 $12.7 Million
Q4 2019 Feb 13, 2020	SELL	$288.29 - $335.49 $131,748 - $153,318	-457 Reduced 0.94%	48,268 $16 Million
Q3 2019 Nov 12, 2019	SELL	$266.84 - $378.23 $1.16 Million - $1.65 Million	-4,358 Reduced 8.21%	48,725 $14.8 Million
Q2 2019 Aug 13, 2019	SELL	$300.59 - $368.15 $6.62 Million - $8.11 Million	-22,028 Reduced 29.33%	53,083 $19.5 Million
Q1 2019 May 14, 2019	BUY	$272.57 - $321.18 $1.5 Million - $1.77 Million	5,509 Added 7.92%	75,111 $23.3 Million
Q4 2018 Feb 14, 2019	SELL	$272.46 - $366.54 $393,704 - $529,650	-1,445 Reduced 2.03%	69,602 $20.9 Million
Q3 2018 Nov 13, 2018	SELL	$279.04 - $367.06 $2.48 Million - $3.26 Million	-8,879 Reduced 11.11%	71,047 $26.1 Million
Q2 2018 Aug 13, 2018	BUY	$228.17 - $292.07 $2.22 Million - $2.84 Million	9,730 Added 13.86%	79,926 $22.3 Million
Q1 2018 May 15, 2018	SELL	$209.54 - $253.91 $907,098 - $1.1 Million	-4,329 Reduced 5.81%	70,196 $16.6 Million
Q4 2017 Feb 14, 2018	BUY	$202.23 - $230.03 $415,178 - $472,251	2,053 Added 2.83%	74,525 $16.3 Million
Q3 2017 Nov 13, 2017	BUY	$172.3 - $213.93 $12.5 Million - $15.5 Million	72,472	72,472 $14.4 Million

Others Institutions Holding ILMN

# of Institutions

900

Shares Held

137M

Call Options Held

1.22M

Put Options Held

1.43M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $21.2B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account